KEYMED BIO-B (02162) Appoints Zhao Jingmei, Qin Chuan and Zhu Bo as Independent Non-Executive Directors

date
20:49 20/11/2026
avatar
GMT Eight
KEYMED BIO-B (02162) announced that Professor Wang Xiaofan, Professor Ke Yang and Mr. Luo Zhuojian have resigned from their respective positions as independent non-executive directors, effective from November 20, 2026. Professor Wang Xiaofan will also cease to serve as chairman of the company's remuneration committee and a member of the nomination committee; Professor Ke Yang will also cease to serve as a member of the audit committee, remuneration committee and nomination committee; and Mr. Luo Zhuojian will also cease to serve as chairman of the audit committee.
KEYMED BIO-B (02162) announced that Professor Wang Xiaofan, Professor Ke Yang and Mr. Luo Zhuojian have resigned from their respective positions as independent non-executive directors, effective from November 20, 2026. Professor Wang Xiaofan will also cease to serve as chairman of the company's remuneration committee and member of the nomination committee; Professor Ke Yang will also cease to serve as a member of the company's audit committee, remuneration committee and nomination committee; and Mr. Luo Zhuojian will also cease to serve as chairman of the audit committee. Effective from November 20, 2026, Professor Zhao Jingmei, Dr. Qin Chuan and Professor Zhu Bo have been appointed as independent non-executive directors. Professor Zhao Jingmei has been appointed as a member of the audit committee, remuneration committee and nomination committee; Dr. Qin Chuan has been appointed as chairman of the remuneration committee and a member of the nomination committee; and Professor Zhu Bo has been appointed as chairman of the audit committee.